Sumanta Pal, Professor and Vice Chair of Academic Affairs at City of Hope, shared on X:
“One of the coolest sessions at Uromigo Live – clinical trial proposals from rising stars!
Glad to be paired with Aly-Khan Lalani, who crafted a really clever prospective trial assessing patients with low KIM1, randomizing to pembro v surveillance. Using a novel WIN Ratio is a means of getting some preliminary evidence. See the photo of him below, dominating the stage both literally and figuratively!
Great job Aly Khan!”

Other articles about Uromigo Live on OncoDaily.